BGPartner has advised Novo Holdings and LifeArc Ventures; VISCHER advised GlycoEra AG.GlycoEra Ltd, a Swiss biotechnology company specializing in innovative treatments for autoimmune diseases, has announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
